SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

NOVARTIS: Click to view the issuer\'s details

Last update : 28/01/2011  >View issuer details

2021.10.19 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis and world’s #1 killer - HTML (w)

2021.10.11 | 09:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sandoz completes acquisition of GSK’s cephalosporin business, reinforcing leading global position in antibiotics - HTML (w)

2021.10.01 | 17:52 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regarding Generic Drugs - HTML (w)

2021.09.08 | 13:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sandoz strengthens pipeline by entering into agreement for biosimilar bevacizumab, a key oncology medicine - HTML (w)

2021.07.21 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis delivered strong Q2 performance, driven by momentum of key growth brands. FY 2021 guidance unchanged. - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1438